Heartbeam, INC Form 4 insider transactions

HeartBeam's CFO, Tim Cruickshank, reported the beneficial ownership of 17,647 common shares and a grant of 23,333 restricted stock units.

HeartBeam Director Richard Ferrari filed a Form 4 detailing his direct and indirect common stock holdings and recent restricted stock unit grants.

HeartBeam, Inc. Director George de Urioste reported the acquisition of restricted stock units and stock options, aligning his interests with shareholders.

HeartBeam Director Michael R. Jaff reported the grant of 78,664 restricted stock units (RSUs) with future vesting dates, alongside current beneficial ownership of 75,120 common shares.

HeartBeam, Inc. President Robert Paul Eno was granted 24,242 Restricted Stock Units (RSUs) under the company's 2022 Equity Incentive Plan.

HeartBeam Director and 10% owner Mark E. Strome reports new grants of restricted stock units and stock options, alongside significant existing beneficial ownership.

HeartBeam Director Kenneth Warwick Nelson III reported the grant of 75,634 Restricted Stock Units (RSUs) and beneficial ownership of 127,147 common shares.

HeartBeam CEO Branislav Vajdic reports changes in his beneficial ownership of common stock and derivative securities, including new option grants.

HeartBeam, Inc. Director Marga Ortigas-Wedekind was granted restricted stock units and stock options, aligning her interests with shareholders.

HeartBeam Director Willem Elfrink reported an increase in his beneficial ownership through direct stock holdings, indirect trust holdings, and new equity awards including restricted stock units and stock options.

HeartBeam's CFO, Tim Cruickshank, was granted 150,000 stock options on April 7, 2025, according to a recent SEC Form 4 filing.

HeartBeam, Inc. CEO Robert Paul Eno reports the acquisition of stock options.

Kenneth Harry Persen, Chief Technology Officer of HeartBeam, Inc., reports the acquisition of 20,000 stock options.

Branislav Vajdic, President of HeartBeam, Inc., reports the acquisition of stock options.

Director Richard Ferrari reports purchasing shares of HeartBeam, Inc. and holding options to buy additional shares.

HeartBeam CFO Tim Cruickshank reports the acquisition of common stock and stock options, signaling changes in beneficial ownership.

A HeartBeam, Inc. director, George de Urioste, sold 1,674 shares of common stock on September 6, 2024, to cover tax withholding obligations related to vested restricted stock units.

Director George de Urioste sold 5,500 shares of HeartBeam, Inc. to cover tax obligations related to vested restricted stock units.

Director George de Urioste sold 2,194 shares of HeartBeam, Inc. stock to cover tax withholding obligations related to vested restricted stock units.

George de Urioste, a director at HeartBeam, Inc., sold shares of common stock to cover tax withholding obligations related to the vesting of restricted stock units.

Director Kenneth Warwick Nelson III reports acquisition and disposal of HeartBeam, Inc. securities, including restricted stock units and options.

Director Michael Jaff of HeartBeam, Inc. reports acquiring and disposing of common stock and holding restricted stock units.

Director Willem Elfrink reports acquisition and disposal of HeartBeam, Inc. stock and holdings in derivative securities.

Director Mark Strome reports acquisition of restricted stock units and disposal of common stock in HeartBeam, Inc.

Director George de Urioste reports acquisition and disposal of HeartBeam, Inc. common stock and restricted stock units.

Director Richard Ferrari reports acquisition and disposal of HeartBeam, Inc. stock and stock units.

Director Marga Ortigas-Wedekind reports acquiring common stock and stock units in HeartBeam, Inc.